EGFR and skin squamous cell carcinoma: Along those lines, the observed co-essentiality coupling of EGFR, which is broadly expressed in tumors, to the integrin signaling network nominates combined inhibition of EGFR and integrin signaling for treatment of advanced cSCC (Figure 7G) (Maubec et al., 2011).